Rex Bionics stock almost halves in value after sales warning

Rex Bionics stock almost halves in value after sales warning
By Paul McBeth Dec. 22 (BusinessDesk) - Rex Bionics, the New Zealand company listed on the London Stock Exchange’s growth-orientated AIM market, almost halved in value last week after it warned that commercial sales will take longer than expected to eventuate. The London-based company, which builds robotic exoskeletons that allows wheelchair users to walk, expects "only a nominal amount" of sales in the year ending March 31, with "some improvement" in the first half of the 2016 financial year, "with a stronger growth trajectory" towards t...